Lbiati Kaouthar's most recent trade in Hepion Pharmaceuticals Inc was a trade of 85,000 Stock Options done . Disclosure was reported to the exchange on Feb. 19, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Hepion Pharmaceuticals Inc | Lbiati Kaouthar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 85,000 | 88,000 | - | - | Stock Options |